REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Genscript Biotech (Singapore) Pte. Ltd. (Singapore)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: All Other Miscellaneous Manufacturing
Full name: Genscript Biotech (Singapore) Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: research and experimental development on biotechnology (excluding medical science); Secondary Business Activity: other manufacturing industries n.e.c. (manufacture of other biological products and preparations)

Headquarters
164 Kallang Way, #06-12 Solaris @Kallang 164, Singapore
Singapore; Singapore; Postal Code: 349248

Contact Details: Purchase the Genscript Biotech (Singapore) Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Genscript Biotech (Singapore) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Genscript Biotech (Singapore) Pte. Ltd. report to view the information.
Incorporation Date:
November 28, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Genscript Biotech (Singapore) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
130.07%▲
Total operating revenue
130.07%▲
Net Profit (Loss) for the Period
N/A
Total assets
52.86%▲
Total equity
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-33.13%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo